Clinical Trial: NCT01905046
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 3| Lead Sponsor: | Alliance for Clinical Trials in Oncology |
| Information Provided By: | Alliance for Clinical Trials in Oncology |
| Last Update Posted: | 2026-10-08 |
Study Overview
Brief Summary
This phase III trial studies how well metformin hydrochloride works compared to placebo in preventing breast cancer in patients with atypical hyperplasia or in situ breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of metformin hydrochloride may prevent breast cancer.
Official Title
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Conditions
Breast Atypical Ductal Hyperplasia, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
Intervention / Treatment
- Drug: metformin hydrochloride
- Other: placebo
Other Study ID Numbers
- A211102
- U10CA031946
- NCI-2013-00995
Start Date (Actual)
2015-11-23
Primary Completion Date (Actual)
2023-11-10
Study Completion Date (Estimated)
2026-11
Enrollment (Actual)
86
Study Type
Interventional
Phase
Phase 3
| Lead Sponsor: | Alliance for Clinical Trials in Oncology |
| Information Provided By: | Alliance for Clinical Trials in Oncology |
| Last Update Posted: | 2026-10-08 |
Study Overview
Brief Summary
This phase III trial studies how well metformin hydrochloride works compared to placebo in preventing breast cancer in patients with atypical hyperplasia or in situ breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of metformin hydrochloride may prevent breast cancer.
Official Title
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Conditions
Breast Atypical Ductal Hyperplasia, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
Intervention / Treatment
- Drug: metformin hydrochloride
- Other: placebo
Other Study ID Numbers
- A211102
- U10CA031946
- NCI-2013-00995
Start Date (Actual)
2015-11-23
Primary Completion Date (Actual)
2023-11-10
Study Completion Date (Estimated)
2026-11
Enrollment (Actual)
86
Study Type
Interventional
Phase
Phase 3